Yinan Liu

机构：Sun Yat-sen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Liuzhou Maternal and Child Health Hospital, Institute of Experimental Physics of the Slovak Academy of Sciences, Peking University Cancer Hospital, The First Affiliated Hospital, Sun Yat-sen University, National Taiwan University Hospital, China Academy of Chinese Medical Sciences · ORCID：0000-0001-7148-5680

发表论文 51 篇 · 总被引 1409 次 · h-index 17

代表论文

• Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial (2023 · Lung Cancer · 被引 115)
• Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib (2020 · The Oncologist · 被引 25)
• miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 (2023 · Molecular Therapy — Nucleic Acids · 被引 20)
• Butylphthalide alleviates sleep deprivation-induced cognitive deficit by regulating Nrf2/HO-1 pathway (2022 · Sleep Medicine · 被引 19)
• Growth and tissue calcium and phosphorus deposition of juvenile discus fish (Symphysodon haraldi) fed with graded levels of calcium and phosphorus (2021 · Aquaculture · 被引 17)
• Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis (2024 · The Journal of Pathology Clinical Research · 被引 15)